1. DOP11 Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis. (25th January 2019) Authors: Slevin, S; Tan, M; Lahiff, C; Wang, L M; Greenaway, B; Lynch, K; Geremia, A; Hughes, S; Leavens, K; Nevin, K; Marks, D J B; Tarzi, R; Srinivasan, N; Travis, S; Arancibia, C; Keshav, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P449 Selective depletion of LAG3+ cells in T-cell-driven inflammation: a randomised, double-blind, placebo-controlled, FTIH phase I/Ib clinical trial. (25th January 2019) Authors: Ellis, J; Marks, D; Barrett, C; Hopkins, T; Richards, A; Fuhr, R; Albayaty, M; Coenen, M; Liefaard, L; Leavens, K; Nevin, K; Tang, S; Hughes, S; Srinivasan, N; Edwards, K; Anselm, R; Schmidt, T; Stone, J; Savage, C; Wisniacki, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗